211 related articles for article (PubMed ID: 27566838)
41. Recurrent V75M mutation within the Wiskott-Aldrich syndrome protein: description of a homozygous female patient.
Proust A; Guillet B; Pellier I; Rachieru P; Hoarau C; Claeyssens S; Léonard C; Charrier S; Vainchenker W; Tchernia G; Delaunay J
Eur J Haematol; 2005 Jul; 75(1):54-9. PubMed ID: 15946311
[TBL] [Abstract][Full Text] [Related]
42. Mediastinal seminoma in a patient with Wiskott-Aldrich syndrome.
Snyder KM; Rubin MA; Shulkin BL; Hutchinson RJ; Wechsler DS
J Pediatr Hematol Oncol; 2002 Nov; 24(8):672-6. PubMed ID: 12439043
[TBL] [Abstract][Full Text] [Related]
43. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients.
Emir S; Vezir E; Azkur D; Demir HA; Metin A
Pediatr Hematol Oncol; 2013 Sep; 30(6):544-53. PubMed ID: 23647505
[TBL] [Abstract][Full Text] [Related]
45. Primary malignant reticulosis of the brain in Wiskott-Aldrich syndrome. Report of a case.
Brand MM; Marinkovich VA
Arch Dis Child; 1969 Aug; 44(236):536-42. PubMed ID: 5803647
[No Abstract] [Full Text] [Related]
46. A rare case of Wiskott-Aldrich Syndrome with normal platelet size: a case report.
Baharin MF; Dhaliwal JS; Sarachandran SV; Idris SZ; Yeoh SL
J Med Case Rep; 2016 Jun; 10(1):188. PubMed ID: 27356510
[TBL] [Abstract][Full Text] [Related]
47. Microthrombocytopenia in a male infant with cytomegalovirus.
Krishnan KR; Vega R
Ann Allergy Asthma Immunol; 2009 Sep; 103(3):268-9. PubMed ID: 19788027
[No Abstract] [Full Text] [Related]
48. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
49. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
Ariga T
Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
[TBL] [Abstract][Full Text] [Related]
50. Urgent minimal invasive treatment of a dental trauma in a child with Wiskott-Aldrich syndrome.
Salazar SL; Soares TR; Maia LC
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):573-5. PubMed ID: 23358227
[TBL] [Abstract][Full Text] [Related]
51. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
[TBL] [Abstract][Full Text] [Related]
52. [Deafness at Wiskott-Aldrich-syndrome].
Zwickl A; Tauber S; Issing WJ
Laryngorhinootologie; 2007 Apr; 86(4):291-5. PubMed ID: 17252322
[TBL] [Abstract][Full Text] [Related]
53. Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features.
Watanabe N; Yoshimi A; Kamachi Y; Kawabe T; Muramatsu H; Matsumoto K; Manabe A; Kojima S; Kato K
J Pediatr Hematol Oncol; 2007 Dec; 29(12):836-8. PubMed ID: 18090932
[TBL] [Abstract][Full Text] [Related]
54. Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
Proust A; Guillet B; Picard C; de Saint Basile G; Pondarré C; Tamary H; Dreyfus M; Tchernia G; Fischer A; Delaunay J
Blood Cells Mol Dis; 2007; 39(1):102-6. PubMed ID: 17400488
[TBL] [Abstract][Full Text] [Related]
55. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
Patel PD; Samanich JM; Mitchell WB; Manwani D
Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
[TBL] [Abstract][Full Text] [Related]
56. [Malignant cutaneous lymphoma in a case of Wiskott-Aldrich syndrome with long-term survival].
Ghilardi G; Pecis C; Bortolani EM; De Bitonto A
Minerva Med; 1990 May; 81(5):427-31. PubMed ID: 2377309
[TBL] [Abstract][Full Text] [Related]
57. Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome.
Pasic S; Vujic D; Djuricic S; Jevtic D; Grujic B
J Pediatr Hematol Oncol; 2006 Jan; 28(1):48-9. PubMed ID: 16394894
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
Braun CJ; Boztug K; Paruzynski A; Witzel M; Schwarzer A; Rothe M; Modlich U; Beier R; Göhring G; Steinemann D; Fronza R; Ball CR; Haemmerle R; Naundorf S; Kühlcke K; Rose M; Fraser C; Mathias L; Ferrari R; Abboud MR; Al-Herz W; Kondratenko I; Maródi L; Glimm H; Schlegelberger B; Schambach A; Albert MH; Schmidt M; von Kalle C; Klein C
Sci Transl Med; 2014 Mar; 6(227):227ra33. PubMed ID: 24622513
[TBL] [Abstract][Full Text] [Related]
59. Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.
Koga Y; Takada H; Suminoe A; Ohga S; Hara T
Pediatr Transplant; 2014 Sep; 18(6):E208-11. PubMed ID: 24930759
[TBL] [Abstract][Full Text] [Related]
60. Long-term survival following non-Hodgkin's lymphoma arising in Wiskott-Aldrich syndrome.
Gilson D; Taylor RE
Clin Oncol (R Coll Radiol); 1999; 11(4):283-5. PubMed ID: 10473730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
